Shanghai Xuerong Bio-Technology Co Ltd Working Capital to Net Assets Ratio
Shanghai Xuerong Bio-Technology Co Ltd working capital to net assets ratio. Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Working Capital to Net Assets ratio of -89.3% as of June 2025. Working capital of CN¥-1.05 Billion (current assets of CN¥469.65 Million minus current liabilities of CN¥1.52 Billion) is measured against net assets of CN¥1.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Shanghai Xuerong Bio-Technology Co Ltd to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shanghai Xuerong Bio-Technology Co Ltd (2015–2024)
Working capital to net assets ratio of Shanghai Xuerong Bio-Technology Co Ltd from 2015 to 2024. This chart shows how Shanghai Xuerong Bio-Technology Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at -89.3%, reflecting working capital of CN¥-1.05 Billion against net assets of CN¥1.17 Billion CNY. See operational self-sufficiency of Shanghai Xuerong Bio-Technology Co Ltd to measure how many days the company can operate on defensive assets alone.
Shanghai Xuerong Bio-Technology Co Ltd Working Capital to Net Assets Ratio by Year (2015–2024)
Shanghai Xuerong Bio-Technology Co Ltd working capital to net assets ratio by year from 2015 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Xuerong Bio-Technology Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Shanghai Xuerong Bio-Technology Co Ltd total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -170.3% | CN¥-1.40 Billion | CN¥823.32 Million | CN¥546.31 Million | CN¥1.95 Billion | ▼ -76.3 pp |
| 2023 | -94.0% | CN¥-1.35 Billion | CN¥1.43 Billion | CN¥766.60 Million | CN¥2.11 Billion | ▼ -87.5 pp |
| 2022 | -6.5% | CN¥-104.97 Million | CN¥1.63 Billion | CN¥1.19 Billion | CN¥1.30 Billion | ▲ +37.8 pp |
| 2021 | -44.2% | CN¥-731.70 Million | CN¥1.65 Billion | CN¥874.94 Million | CN¥1.61 Billion | ▼ -36.5 pp |
| 2020 | -7.7% | CN¥-156.74 Million | CN¥2.02 Billion | CN¥1.23 Billion | CN¥1.39 Billion | ▲ +25.9 pp |
| 2019 | -33.7% | CN¥-585.61 Million | CN¥1.74 Billion | CN¥701.13 Million | CN¥1.29 Billion | ▲ +3.8 pp |
| 2018 | -37.4% | CN¥-587.31 Million | CN¥1.57 Billion | CN¥805.89 Million | CN¥1.39 Billion | ▲ +32.6 pp |
| 2017 | -70.0% | CN¥-991.13 Million | CN¥1.42 Billion | CN¥588.60 Million | CN¥1.58 Billion | ▼ -29.0 pp |
| 2016 | -40.9% | CN¥-528.02 Million | CN¥1.29 Billion | CN¥406.37 Million | CN¥934.39 Million | ▲ +50.0 pp |
| 2015 | -91.0% | CN¥-584.83 Million | CN¥642.99 Million | CN¥307.90 Million | CN¥892.73 Million | — |